Patents/Assignees

Nanjing Southern Element Biotechnology Co., Ltd.

1 patent in portfolio

US11819514utility2023
Use of Oligosaccharide Riclinoctaose in Preparation of Drug for Treating And/or Preventing Ischemia-reperfusion Injury (IRI)
0 cites